Long-term potentiation at excitatory amino acid synapses on midbrain dopamine neurons

NeuroReport

Volumn 10, Issue 2, 1999, Pages 221-226

  Overton, Paul G ^a   Richards, Christopher D ^a   Berry, Michael S ^a   Clark, David ^a  

^a SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

Addiction; LTP; NMDA; Rat; Sensitization; Short term potentiation; STP

Indexed keywords

2 AMINO 7 PHOSPHONOHEPTANOIC ACID; 4 (3 PHOSPHONOPROPYL) 2 PIPERAZINECARBOXYLIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; DIZOCILPINE; DOPAMINE; EXCITATORY AMINO ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; EXCITATORY POSTSYNAPTIC POTENTIAL; LONG TERM POTENTIATION; MALE; MESENCEPHALON; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; SYNAPSE;

EID: 0033525149     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199902050-00004     Document Type: Article

References (25)

1. Robinson TE and Berridge KC. Brain Res Rev 18, 247-291 (1993).
2. Bliss TVP and Collingridge GL. Nature 361, 31-39 (1993).
3. Clark D and Overton PG. Addict Biol 3, 109-135 (1998).
4. Karler R, Chaudhry IA, Calder L and Turkanis SA. Brain Res 537, 76-82 (1990).
5. Kalivas PW and Alesdatter JE. J Pharmacol Exp Ther 267, 486-495 (1993)
6. White FJ, Xiu-Ti HU, Zhang X-F and Wolf ME. J Pharmacol Exp Ther 273, 445-454 (1995).
7. Zhang XF, Hu XT, White FJ and Wolf ME. J Pharmacol Exp Ther 281, 699-706 (1997).
8. Tong Z-Y, Overton PG and Clark D. Brain Res 674, 63-74 (1995).
9. Wolf ME. Prog Neurobiol 54, 679-720 (1998).
10. Häusser MA and Yung WH. J Physiol 479, 401-422 (1994).
11. Richards CD, Shiroyama T and Kitai ST. Neuroscience 80, 545-557 (1997).
12. Frankiewicz T, Potier B, Bashir Zl et al. Br J Pharmacol 117, 689-697 (1996).
13. Hrabetova S and Sacktor TC. Neurosci Lett 226, 107-110 (1997).
14. Artola A and Singer W Trends Neurosci 16, 480-487 (1993).
15. Oliet SH, Malenka RC and Nicoll RA. Neuron 18, 969-982 (1997).
16. Wolf ME and Jeziorski M. Brain Res 613, 291-294 (1993).
17. Goldman-Rakic PS. Adv Pharmacol 42, 707-711 (1998).
18. Homykiewicz O. Res Publ Assoc Res Nerv Ment Dis 50, 390-415 (1972).
19. Dray A. Prog Neurobiol 14, 221-335 (1980).
20. Reynolds GP. Br J Psychiatry 155, 305-316 (1989).
21. Marsden CD and Jenner P. Psychol Med 10, 55-72 (1980).
22. Clarke CE, Sambrook MA, Mitchell IJ and Crossman AR. J Neurol Sci 78, 273-280 (1987).
23. Stocchi F, Nordera G and Marsden CD. Clin Neuropharmacol 20, 95-115 (1997).
24. Turski L and Turski WA. Experientia 49, 1064-1072 (1993)
25. Maldrum B and Garthwaite J. Trends Pharmacol Sci 11, 379-387 (1990).